Analyst firms · Barclays · QRVO
Barclays QRVO price target and rating history
Qorvo Inc. (QRVO) · Technology
Barclays rates Qorvo Inc. (QRVO) Overweight with a $100 price target, as of its latest action on Apr 22, 2026. It has published 4 rating actions on QRVO since June 2021, including 1 upgrade and 1 downgrade. Across 4 firms with a QRVO price target in the last 12 months, the median target is $87.50. Barclays's $100 is 14% above that.
- Current rating
- Overweight
- Price target
- $100
- Median target, all firms
- $87.50
- Actions on QRVO
- 4
Barclays price target on QRVO
Every Barclays rating on QRVO
- Apr 22, 2026
- Oct 24, 2022
- Feb 3, 2022
- Jun 29, 2021
How other firms rate QRVO
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Barclays | Overweight | $100 | Apr 22, 2026 |
| Mizuho | Underperform | $66 | Apr 20, 2026 |
| Wolfe Research | Peer Perform | Apr 17, 2026 | |
| Craig-Hallum | Buy | $95 | Jan 28, 2026 |
| TD Cowen | Hold | $80 | Jan 28, 2026 |
Questions about Barclays and QRVO
- What is Barclays's price target for QRVO?
- Barclays's latest stated price target for Qorvo Inc. (QRVO) is $100, from its action on Apr 22, 2026.
- What is Barclays's rating on QRVO?
- Barclays rates QRVO Overweight, a bullish rating, as of Apr 22, 2026.
- When did Barclays last change its view on QRVO?
- On Apr 22, 2026, Barclays upgrades to Overweight from Equal Weight, price target $100.
- How does Barclays's QRVO target compare with other analysts?
- Across 4 firms with a QRVO price target in the last 12 months, the median target is $87.50. Barclays's $100 is 14% above that.
More QRVO rating histories
- Mizuho6
- Craig-Hallum3
- TD Cowen8
- Morgan Stanley8
- The Benchmark Company6
- Piper Sandler3
- Raymond James3
- BNP Paribas Exane3
- Summit Insights4
- BofA Securities4
- Rosenblatt3
- Oppenheimer3
All Barclays ratingsQRVO news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.